Related Experiment Video
Updated: Jan 22, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
7.6K
Summary
The Meningococcal B (MenB) vaccine, approved in 2014, protects against a specific type of bacterial meningitis. Many patients mistakenly believe an older vaccine covers MenB, leading to potential protection gaps.
Area of Science:
- Public Health
- Vaccinology
- Pediatrics
Background:
- Meningococcal disease is a serious bacterial infection.
- The Meningococcal B (MenB) vaccine received FDA approval in 2014.
- An older vaccine exists for other serogroups of meningococcal bacteria.
Purpose of the Study:
- To highlight the distinction between the MenB vaccine and older meningococcal vaccines.
- To address the common misconception that existing vaccination provides MenB protection.
- To inform healthcare providers about potential patient misunderstandings regarding MenB immunity.
Main Methods:
- Review of vaccine approval timelines and existing immunization schedules.
- Analysis of public and physician awareness regarding different meningococcal vaccines.
- Identification of knowledge gaps concerning MenB-specific protection.
Main Results:
- The MenB vaccine is a recent addition to the vaccine landscape.
- A significant portion of the population may lack awareness of MenB-specific protection.
- Confusion exists due to the availability of vaccines for other meningococcal serogroups.
Conclusions:
- Physicians must actively educate patients about the MenB vaccine's specific coverage.
- Clear communication is essential to prevent under-vaccination against Meningococcal B disease.
- Ensuring accurate understanding of MenB vaccine status is crucial for adolescent and child health.
More Related Videos
Related Concept Videos
01:17Sleepwalking and Sleep Talking
928
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
928
01:13Patient-centered Care
2.9K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
01:21Drug Dosing: Obese Patients
235
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
235
01:15Drug Dosing: Geriatric Patients
229
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
229
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
269
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
269
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
198
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
198